{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:38:23Z","timestamp":1793968703085,"version":"4.8.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jad.2023.01.005","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T20:15:23Z","timestamp":1673036123000},"page":"127-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Antidepressant and anti-suicidal effects of ketamine in treatment-resistant depression associated with psychiatric and personality comorbidities: A double-blind randomized trial"],"prefix":"10.1016","volume":"325","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5830-4117","authenticated-orcid":false,"given":"Gellan K.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser M.","family":"Elserogy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada Mohammad Abo","family":"Elfadl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ghada Abdelsalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2023.01.005_bb0005","series-title":"Psychological assessment of patients with male erectile disorder in Assiut","author":"Abdulrakeeb AEM","year":"2003"},{"key":"10.1016\/j.jad.2023.01.005_bb0010","series-title":"Symptom Checklist-90 (SCL-90), Arabic Form","author":"Al Behairy","year":"1984"},{"key":"10.1016\/j.jad.2023.01.005_bb0015","series-title":"Suicide Probability Scale (translated and validated by Dr Abd Al Rakib Al Behairy)","author":"Al Behairy","year":"2003"},{"key":"10.1016\/j.jad.2023.01.005_bb0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpsychires.2014.07.027","article-title":"Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety","volume":"58","author":"Ballard","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2023.01.005_bb0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/000486748902300320","article-title":"Development of a scale to measure interpersonal sensitivity","volume":"23","author":"Boyce","year":"1989","journal-title":"Aust.N.Z.J.Psychiatry"},{"key":"10.1016\/j.jad.2023.01.005_bb0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/00048679209072022","article-title":"Interpersonal sensitivity and the one-year outcome of a depressive episode","volume":"26","author":"Boyce","year":"1992","journal-title":"Aust.N.Z.J.Psychiatry"},{"key":"10.1016\/j.jad.2023.01.005_bb0035","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/0706743719828965","article-title":"Current and common definitions of treatment-resistant depression: findings from a systematic review and qualitative interviews","volume":"64","author":"Brown","year":"2019","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.01.005_bb0040","series-title":"Focus","first-page":"55","article-title":"Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study","volume":"17","author":"Canuso","year":"2019"},{"key":"10.1016\/j.jad.2023.01.005_bb0045","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/s41386-019-0480-y","article-title":"Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo-control study","volume":"44","author":"Chen","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2023.01.005_bb0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/070674370404900205","article-title":"The 5-factor model of personality and antidepressant medication compliance","volume":"49","author":"Cohen","year":"2004","journal-title":"Can. J. psychiatry"},{"key":"10.1016\/j.jad.2023.01.005_bb6000","series-title":"Los Angeles: Western Psychcological Services","article-title":"Suicide probability scale (SPS) manual","author":"Cull","year":"1988"},{"key":"10.1016\/j.jad.2023.01.005_bb0055","series-title":"Guideline on clinical investigation of medicinal products in the treatment of depression, in: (CHMP), C.f.M.P.f.H.U. (Ed.), EMA\/CHMP\/185423\/2010 Rev. 2 previously (CPMP\/EWP\/518\/97, Rev. 1) ed","author":"European Medicines Agency","year":"2013"},{"key":"10.1016\/j.jad.2023.01.005_bb0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/0004867416631828","article-title":"Ketamine augmentation for outpatients with treatment-resistant depression: preliminary evidence for two-step intravenous dose escalation","volume":"51","author":"Cusin","year":"2017","journal-title":"Aust.N.Z.J.Psychiatry"},{"key":"10.1016\/j.jad.2023.01.005_bb0065","series-title":"The SCL\u201390\u2013R And Brief Symptom Inventory (BSI) in Primary Care","author":"Derogatis","year":"2000"},{"key":"10.1016\/j.jad.2023.01.005_bb0070","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4088\/JCP.09m05327blu","article-title":"Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder","volume":"71","author":"DiazGranados","year":"2010","journal-title":"J.Clin.Psychiatry"},{"key":"10.1016\/j.jad.2023.01.005_bb0075","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/da.22975","article-title":"Ketamine for acute suicidal ideation. An emergency department intervention: a randomized, double-blind, placebo-controlled, proof-of-concept trial","volume":"37","author":"Domany","year":"2020","journal-title":"Depress.Anxiety"},{"key":"10.1016\/j.jad.2023.01.005_bb0080","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.18632\/oncotarget.13743","article-title":"Ketamine rapidly relieves acute suicidal ideation in cancer patients: a randomized controlled clinical trial","volume":"8","author":"Fan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jad.2023.01.005_bb0085","series-title":"Arabic Manual of Hamilton Anxiety Scale","author":"Fateem","year":"1998"},{"key":"10.1016\/j.jad.2023.01.005_bb0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jad.2008.10.014","article-title":"What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies","volume":"116","author":"Fekadu","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.01.005_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.pscychresns.2021.111369","article-title":"Six-week oral ketamine treatment for chronic suicidality is associated with increased grey matter volume","volume":"317","author":"Gallay","year":"2021","journal-title":"Psychiatry research. Neuroimaging"},{"key":"10.1016\/j.jad.2023.01.005_bb0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40211-017-0248-8","article-title":"Suicide risk in somatoform disorders","volume":"32","author":"Giupponi","year":"2018","journal-title":"Neuropsychiatrie"},{"key":"10.1016\/j.jad.2023.01.005_bb0105","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1016\/j.amepre.2014.06.012","article-title":"Existing and novel biological therapeutics in suicide prevention","volume":"47","author":"Griffiths","year":"2014","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.jad.2023.01.005_bb0110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1176\/appi.ajp.2017.17060647","article-title":"Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial","volume":"175","author":"Grunebaum","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.01.005_bb0115","series-title":"Group1","first-page":"4","article-title":"Hamilton depression scale","author":"Hamilton","year":"1976"},{"key":"10.1016\/j.jad.2023.01.005_bb0120","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4088\/JCP.v63n0913","article-title":"Partial response and nonresponse to antidepressant therapy: current approaches and treatment options","volume":"63","author":"Hirschfeld","year":"2002","journal-title":"J.Clin.Psychiatry"},{"key":"10.1016\/j.jad.2023.01.005_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106524","article-title":"The rapid anti-suicidal ideation effect of ketamine: a systematic review","volume":"152","author":"Hochschild","year":"2021","journal-title":"Prev. Med."},{"key":"10.1016\/j.jad.2023.01.005_bb0130","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.neuron.2019.07.011","article-title":"Enhanced mGlu5 signaling in excitatory neurons promotes rapid antidepressant effects via AMPA receptor activation","volume":"104","author":"Holz","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.jad.2023.01.005_bb0135","doi-asserted-by":"crossref","first-page":"e719","DOI":"10.4088\/JCP.15m10056","article-title":"Rapid and sustained reductions in current suicidal ideation following repeated doses of intravenous ketamine: secondary analysis of an open-label study","volume":"77","author":"Ionescu","year":"2016","journal-title":"J.Clin.Psychiatry"},{"key":"10.1016\/j.jad.2023.01.005_bb0140","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jad.2018.09.037","article-title":"Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: a randomized, double blind, placebo controlled trial","volume":"243","author":"Ionescu","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.01.005_bb0145","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jad.2018.06.045","article-title":"The burden of treatment-resistant depression: a systematic review of the economic and quality of life literature","volume":"242","author":"Johnston","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.01.005_bb0150","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jad.2012.04.026","article-title":"Do antidepressants change personality?\u2013a five-year observational study","volume":"142","author":"Jylh\u00e4","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.01.005_bb0155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/archfami.9.1.46","article-title":"Somatoform symptoms and treatment nonadherence in depressed family medicine outpatients","volume":"9","author":"Keeley","year":"2000","journal-title":"Arch. Fam. Med."},{"key":"10.1016\/j.jad.2023.01.005_bb0160","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-clinpsy-021815-093204","article-title":"Suicide, suicide attempts, and suicidal ideation","volume":"12","author":"Klonsky","year":"2016","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.jad.2023.01.005_bb0165","article-title":"Dimensions of temperament and character as predictors of antidepressant discontinuation, response and adverse reactions during treatment with nortriptyline and escitalopram","volume":"1\u20139","author":"K\u00f6hler-Forsberg","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2023.01.005_bb0170","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/1097-4679(198907)45:4<531::AID-JCLP2270450406>3.0.CO;2-K","article-title":"Anger, hostility, and depression in assaultive vs. suicide-attempting males","volume":"45","author":"Maiuro","year":"1989","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.jad.2023.01.005_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.113993","article-title":"The effect of intravenous ketamine on cognitive functions in adults with treatment-resistant major depressive or bipolar disorders: results from the Canadian rapid treatment center of excellence (CRTCE)","volume":"302","author":"McIntyre","year":"2021","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2023.01.005_bb0180","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.01.005_bb0185","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1017\/S0033291715001506","article-title":"Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial","volume":"45","author":"Murrough","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2023.01.005_bb0190","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/NMD.0000000000001050","article-title":"Paranoid ideation without psychosis is associated with depression, anxiety, and suicide attempts in general population","volume":"207","author":"Na","year":"2019","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jad.2023.01.005_bb0195","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.4088\/JCP.v64n1112","article-title":"Psychiatric comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorder","volume":"64","author":"Papakostas","year":"2003","journal-title":"J.Clin.Psychiatry"},{"key":"10.1016\/j.jad.2023.01.005_bb0200","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/sltb.12022","article-title":"Treatment-resistant depression and risk of suicide","volume":"43","author":"Pfeiffer","year":"2013","journal-title":"Suicide Life Threat Behav"},{"key":"10.1016\/j.jad.2023.01.005_bb0205","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1176\/appi.ajp.2018.18070834","article-title":"Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial","volume":"176","author":"Phillips","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.01.005_bb0210","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41386-019-0570-x","article-title":"Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression","volume":"45","author":"Phillips","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2023.01.005_bb0215","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/da.22253","article-title":"Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression","volume":"31","author":"Price","year":"2014","journal-title":"Depress.Anxiety"},{"key":"10.1016\/j.jad.2023.01.005_bb0220","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1037\/bul0000088","article-title":"A systematic review of personality trait change through intervention","volume":"143","author":"Roberts","year":"2017","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.jad.2023.01.005_bb0225","first-page":"627","article-title":"STAR*D: revising conventional wisdom","volume":"23","author":"Rush","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2023.01.005_bb0230","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","article-title":"A consensus statement on the use of ketamine in the treatment of mood disorders","volume":"74","author":"Sanacora","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2023.01.005_bb0235","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.euroneuro.2012.02.006","article-title":"European Group for the Study of Resistant Depression (GSRD)\u2013where have we gone so far: review of clinical and genetic findings","volume":"22","author":"Schosser","year":"2012","journal-title":"Eur.Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2023.01.005_bb0240","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(02)07750-4","article-title":"Allocation concealment in randomised trials: defending against deciphering","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2023.01.005_bb0245","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/archgenpsychiatry.2009.166","article-title":"Personality change during depression treatment: a placebo-controlled trial","volume":"66","author":"Tang","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2023.01.005_bb0250","series-title":"Structured Interview for the Five-factor Model of Personality (SIFFM): Professional Manual","author":"Trull","year":"1997"},{"key":"10.1016\/j.jad.2023.01.005_bb0255","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jad.2016.09.008","article-title":"Continuation phase intravenous ketamine in adults with treatment-resistant depression","volume":"206","author":"Vande Voort","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.01.005_bb0260","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4088\/JCP.15m10440","article-title":"Antisuicidal response following ketamine infusion is associated with decreased nighttime wakefulness in major depressive disorder and bipolar disorder","volume":"78","author":"Vande Voort","year":"2017","journal-title":"J.Clin.Psychiatry"},{"key":"10.1016\/j.jad.2023.01.005_bb0265","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.01.005_bb0270","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2023.01.005_bb0275","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1111\/jocn.14114","article-title":"The relationship of interpersonal sensitivity and depression among patients with chronic atrophic gastritis: the mediating role of coping styles","volume":"27","author":"Zhao","year":"2018","journal-title":"J. Clin. Nurs."},{"key":"10.1016\/j.jad.2023.01.005_bb0280","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpsychires.2018.09.013","article-title":"Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression","volume":"106","author":"Zheng","year":"2018","journal-title":"J. Psychiatr. Res."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723000149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723000149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T03:38:40Z","timestamp":1759030720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032723000149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":57,"alternative-id":["S0165032723000149"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2023.01.005","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant and anti-suicidal effects of ketamine in treatment-resistant depression associated with psychiatric and personality comorbidities: A double-blind randomized trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2023.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}